n investigational stem-cell-derived therapy for people with type 1 diabetes, developed by the Boston-based company Vertex Pharmaceuticals, has been shown to be effective at restoring insulin production in the first person to receive the therapy,
T1D TREATMENT EFFECTIVE IN TRIAL
Feb 19, 2022
1 minute
You’re reading a preview, subscribe to read more.
Start your free 30 days